Laurion Capital Management »

Leap Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.4M 709k 1.96

More positions owned by Laurion Capital Management

Meta Platforms Cl A Call Option (META)
Hess (HES)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
United States Steel Corporation (X)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Netflix Call Option (NFLX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Workday Cl A (WDAY)
General Motors Company (GM)
Boeing Company (BA)
Microsoft Corporation (MSFT)
Ansys (ANSS)
Hubspot (HUBS)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)

View all positions for Laurion Capital Management

Top funds holding Leap Therapeutics

Balyasny Asset Management
Samsara BioCapital
683 Capital Management
Rock Springs Capital Management
Baker Bros. Advisors
Vanguard Group
Citadel Advisors
Laurion Capital Management
Simplify Asset Management
Adage Capital Partners GP
Longwood Capital Partners
Key Client Fiduciary Advisors
Geode Capital Management
Acadian Asset Management
BlackRock

View all funds holding Leap Therapeutics